OrbiMed Capital GP V LLC
CIK 1615374 · last filed 2025-10-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INSP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
54TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | 4,975,291 | $1.30 | $6.47M | $62.31M | 4 | 2025-10-27 |
| CRVS | Director | 8,341,338 | $10.58 | $88.25M | -$9.04M | 3 | 2025-07-01 |
| Tricida, Inc. (TCDA) Delisted | Director | 9,246,526 | $0.11 | $998.6K | $11.79M | 2 | 2022-11-25 |
| CMPX | Director | 14,510,319 | $0.79 | $11.51M | $591.8K | 1 | 2022-05-10 |
| INSP | Director | 158,500 | $72.86 | $11.55M | -$191.94M | 5 | 2020-08-14 |
| ARMO BioSciences, Inc. (ARMO) Delisted | 10%+ Owner | 3,709,356 | — | — | $0 | 1 | 2018-06-22 |
| RYTM | 10%+ Owner | 2,751,679 | $89.98 | $247.60M | $16.91M | 2 | 2018-05-24 |
| ASND | Director | 5,091,010 | $242.35 | $1.23B | $53.27M | 2 | 2018-05-16 |
Recent Filings · Page 2 of 3
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-23 | — | Buy (P) | +2,910,264 | $14.55M | |
| 2020-03-10 | INSP | Sell (S) | −1,000,000 | -$83.52M | EDGAR |
| 2019-11-29 | INSP | Sell (S) | −248,000 | -$17.53M | EDGAR |
| 2019-04-05 | Tricida, Inc. (TCDA) Delisted | Buy (P) | +450,000 | $16.20M | EDGAR |
| 2018-12-13 | INSP | Sell (S) | −1,229,544 | -$46.23M | EDGAR |
| 2018-06-22 | ARMO BioSciences, Inc. (ARMO) Delisted | U | −12,356,709 | -$617.84M | EDGAR |
| 2018-05-24 | RYTM | Sell (S) | −39,160 | -$1.19M | EDGAR |
| 2018-05-16 | ASND | Sell (S) | −20,600 | -$278.1K | EDGAR |
| 2017-10-10 | RYTM | Mixed | +8,703,885 | $18.11M | EDGAR |
| 2016-06-16 | CRVS | Buy (P) | +60,000 | $741.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.